Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Information needed for a submission to comply with the Regulations, licence holders and/or importers of Class II to IV medical …
Health Canada and the Canadian Advertising Preclearance Agencies (APAs) share the common goal of maintaining integrity in health product advertising. …
The objective of this guidance document is to assist industry and interested stakeholders (Market Authorization Holders (MAHs)) in developing a …
Health Canada recognizes that it is important for industry to disseminate non-promotional, accessible information on human and animal health products …
This guidance document was prepared to help medical device manufacturers understand and comply with the Medical Devices Regulations. Two new …
This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to …
This guidance document was prepared to help medical device manufacturers understand and comply with the Medical Devices Regulations. Two new …
Guidance to market authorization holders on issuing health product risk communications: Definitions.
The purpose of this document is to assist market authorization holders (MAHs) develop and disseminate health product risk communications (HPRCs).
…The timeline to develop and disseminate an HPRC should be based on an assessment of the risk associated with a …